Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
Public ClinicalTrials.gov record NCT03326843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding.
Study identification
- NCT ID
- NCT03326843
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 26, 2018 (Actual)
- Primary completion
- Feb 25, 2019 (Actual)
- Completion
- Feb 25, 2019 (Actual)
- Last update posted
- Apr 15, 2020
2018 – 2019
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dova Site | Little Rock | Arkansas | 72205 | — |
| Dova Site | Coronado | California | 92118 | — |
| Dova Site | Aurora | Colorado | 80045 | — |
| Dova Site | Jacksonville | Florida | 32209 | — |
| Dova Site | Jacksonville | Florida | 32224 | — |
| Dova Site | Miami | Florida | 33135 | — |
| Dova Site | Miami | Florida | 33136 | — |
| Dova Site | Pensacola | Florida | 32503 | — |
| Dova Site | Sarasota | Florida | 34232 | — |
| Dova Site | Tamarac | Florida | 33321 | — |
| Dova Site | Tampa | Florida | 33615 | — |
| Dova Site | New Orleans | Louisiana | 70112 | — |
| Dova Site | Baltimore | Maryland | 21202 | — |
| Dova Site | Boston | Massachusetts | 02115 | — |
| Dova Site | Detroit | Michigan | 48202 | — |
| Dova Site | Springfield | Missouri | 65807 | — |
| Dova Site | St Louis | Missouri | 63110 | — |
| Dova Site | Reno | Nevada | 89503 | — |
| Dova Site | Englewood | New Jersey | 07631 | — |
| Dova Site | Buffalo | New York | 14203 | — |
| Dova Site | Durham | North Carolina | 27710 | — |
| Dova Site | Winston-Salem | North Carolina | 27157 | — |
| Dova Site | Toledo | Ohio | 43606 | — |
| Dova Site | Bethlehem | Pennsylvania | 18015 | — |
| Dova Site | Austin | Texas | 78731 | — |
| Dova Site | Newport News | Virginia | 23602 | — |
| Dova Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03326843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03326843 live on ClinicalTrials.gov.